Skip to content

48 Hours Esophagal pH-monitoring With and Without Gaviscon

48 Hoursesophagal pH-monitoring With and Without Gaviscon

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02783378
Enrollment
50
Registered
2016-05-26
Start date
2016-02-24
Completion date
2017-12-31
Last updated
2018-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux

Keywords

impedance metry, gaviscon

Brief summary

At a esophagal pH-monitoring will the classic 24-hour measurement be extended to 48 hours. During the first 24 hours are the measurements without medication. After 24 hours the treatment will be started with Gaviscon and will the next 24 hours the measurements under the medication happen. Normally is the medication required after the measurements. With this study the investigators will have multiple measurement points to compare.

Detailed description

This is an interventional, with questionnaires. 25 participants will be included. Parents and children must be willing to have the esophagal pH-monitoring for 48 hours instead of 24 hours. The restrictions are (like any other esophagal pH-monitoring) : Do not detach the probe, no bath or shower, no bouncy castle, no swimming pool, .... Give your child time to get used to the probe. Give your child no carbonated beverages, limit sweets, avoid chewing gum! Not study specific procedures : there will be placed a probe for the oesophagal pH-monitoring and this will be checked on children's radiology. study specific procedures : questionnaires at specific times : Before start : SF 36 Every 6 hours during 48hours : FLACC Satisfaction scale at the start, after 1 day and after 2 days Flowchart time 0: obtaining ICF, signed by both parents, placing of probe, explanation of questionnaires, completing SF36 and satisfaction scale time 6: FLACC time 12: FLACC time 18: FLACC time 24: FLACC, satisfaction scale, reading out pH monitoring from the first 24 hours, then starting of Gaviscon in function of the result. The Gaviscon is supplied by the service, at no cost to the patient time 30: FLACC time 36: FLACC time 42: FLACC time 48: FLACC, satisfaction scale, remove pH monitoring Calculation of the number of participants : since there is never such a study was carried out, we started this pilot study. An analysis will be carried out after 15 patients. Analysis of the results : the results of the first and second 24 hour data will be compared (automatically by computer analysis).

Interventions

DRUGGaviscon Syrup

Sponsors

Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 6 Years
Healthy volunteers
No

Inclusion criteria

* children in whom a pH-monitoring was asked * pre school-age children * hospitalized children * parents have the informed consent signed.

Exclusion criteria

: * children over 6 years

Design outcomes

Primary

MeasureTime frameDescription
Incidence of pathological GERD24 and 48 hourschange in pathological GERD from baseline at 24 and 48 hours

Secondary

MeasureTime frameDescription
Effect of Gaviscon on pain in infants with GERD24 and 48 hoursPain assessed via FLACC scale
Effect of Gaviscon on parental concern for parents of infants with GERD24 hours and 48 hoursParental concern assessed via 10 point Likert scale

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026